Life Sciences Innovative Manufacturing Fund
Provides capital support for the United Kingdom life-science manufacturing capability through public programmes for medicines, diagnostics, and medical devices.
About
LSIMF is a £520M capital grants programme running to 31 March 2030, administered by DSIT via the Office for Life Sciences (joint DSIT/DHSC body). It funds UK-registered wholly private-sector companies investing in manufacturing capacity for human medicines, medical diagnostics, and MedTech devices. The maximum intervention rate is 25% of eligible project costs; typical awards are 10–20% of total p…
BiotechAdvanced ManufacturingMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.